UPDATE: Allergan adopts poison pill in face of Valeant bid
UPDATE: U.S. stocks rise; Netflix jumps on results
ALLERGAN INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Allergan, Inc.
Allergan Pursuer Valeant: A Drug Maker With Little Patience for Science
The Deal Announces Candidates For Seventh Annual Most Admired Corporate Dealmakers Awards
Meda and Valeant Terminate Joint Ventures
Widening investment-grade credit spreads and rising interest rates lead to losses.
Fund portfolio and Berkshire Hathaway shareholder data show which funds hold significant chunks of the company's stock.